| | COMPOUND: C07403 | |
Entry |
|
Name |
|
Formula |
C20H24ClN3S
|
Exact mass |
373.1379
|
Mol weight |
373.9427
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05A ANTIPSYCHOTICS
N05AB Phenothiazines with piperazine structure
N05AB04 Prochlorperazine
D00493 Prochlorperazine (JAN/USP/INN) <US>
USP drug classification [BR:br08302]
Antiemetics
Antiemetics, Other
Prochlorperazine
D00493 Prochlorperazine (JAN/USP/INN)
Antipsychotics
1st Generation/Typical
Prochlorperazine
D00493 Prochlorperazine (JAN/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
DG00876 Prochlorperazine
D00493 Prochlorperazine
DG03200 Antipsychotic agent
DG01905 Phenothiazine antipsychotics
DG00876 Prochlorperazine
D00493 Prochlorperazine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD2
D00493 Prochlorperazine (JAN/USP/INN) <US>
|
Other DBs |
|
KCF data |
ATOM 25
1 C8x C 26.6700 -18.5500
2 C8x C 26.6700 -19.9500
3 C8x C 27.8600 -20.6500
4 C8y C 29.1200 -19.9500
5 C8y C 29.1200 -18.5500
6 C8x C 27.8600 -17.8500
7 S2x S 30.3100 -20.6500
8 C8y C 31.5000 -19.9500
9 C8y C 31.5000 -18.5500
10 N4y N 30.3100 -17.8500
11 C8x C 32.7600 -20.6500
12 C8x C 33.9500 -19.9500
13 C8y C 33.9500 -18.5500
14 C8x C 32.7600 -17.8500
15 C1b C 30.3100 -16.4500
16 X Cl 35.1400 -17.8500
17 C1b C 31.5000 -15.7500
18 C1b C 32.6900 -16.4500
19 N1y N 33.8800 -15.7500
20 C1x C 35.0700 -16.4500
21 C1x C 36.3300 -15.7500
22 N1y N 36.3300 -14.3500
23 C1x C 35.1400 -13.6500
24 C1x C 33.8800 -14.3500
25 C1a C 37.5200 -13.6500
BOND 28
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 8 11 2
13 11 12 1
14 12 13 2
15 13 14 1
16 9 14 2
17 10 15 1
18 13 16 1
19 15 17 1
20 17 18 1
21 18 19 1
22 19 20 1
23 20 21 1
24 21 22 1
25 22 23 1
26 23 24 1
27 19 24 1
28 22 25 1
|
|
» Japanese version
|
|